PIMA17346

Hepatitis B Virus Surface Ad/Ay Monoclonal Antibody (F55G), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIMA17346-Each-of-1 In Stock ₹ 47,837.50

PIMA17346 - Each of 1

₹ 47,837.50

In Stock

Quantity

1

Base Price: ₹ 47,837.50

GST (18%): ₹ 8,610.75

Total Price: ₹ 56,448.25

Antigen

Hepatitis B Virus Surface Ad/Ay

Classification

Monoclonal

Concentration

0.1 mg/mL

Formulation

PBS with 0.1% sodium azide; pH 7.2

Host Species

Mouse

Purification Method

Protein A

Regulatory Status

RUO

Target Species

Virus

Product Type

Antibody

Isotype

IgG2a

Applications

ELISA, Immunohistochemistry

Clone

F55G

Conjugate

Unconjugated

Gene Alias

HBsAg; HBV; hepatitis b virus surface antigen; HepB

Immunogen

Hepatitis B Surface antigen.

Quantity

100 μg

Primary or Secondary

Primary

Content And Storage

4° C

Form

Liquid

Related Products

Img

Thermo Scientific

PIMA17344

--

Img

Thermo Scientific

PIMA17467

--

Img

Thermo Scientific

PIMA17294

--

Img

Thermo Scientific

PIMA17408

--

Img

Thermo Scientific

PIMA17358

--

Img

Thermo Scientific

PIMA17276

--

Img

Thermo Scientific

PIMA17312

--

Img

Thermo Scientific

PIMA17333

--

Description

  • The MA1-7346 antibody reacts with Hepatitis B virus sAg
  • capture in viral and infected tissue samples
  • MA1-7346 has been successfully used in ELISA applications
  • The MA1-7346 antibody was raised against Hepatitis B Surface antigen
  • The hepatitis B virus is an important cause of acute and chronic liver disease
  • It is also the most common form of parenterally transmitted viral hepatitis
  • The HBV surface protein antigens (HBsAg) are comprised of three carboxyl co terminal HBs proteins termed large (LHBs), middle (MHBs) and small (SHBs, also called major) protein
  • LHBs and MHBs also share the highly hydrophobic, repetitive, membrane spanning S domain
  • In addition, MHBs has a 55 amino acid region called preS2
  • The virus is estimated to affect some 350 million people worldwide
  • Immunization against hepatitis B is an important component of preventative medicine and is offered to all children in approximately 30 countries
  • Hepatitis B virus (HBV) belongs to the Hepadnaviridae family and infection with HBV is usually more serious than infection with hepatitis A virus
  • In some individuals the infection is not cleared and followed by persistent intracellular viral carriage that can lead to the development of hepatocelular carcinomas
  • There are currently 400 million HBV carriers worldwide making HBV one of the most common human pathogens.